Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Paratonic Rigidity in Advanced Cognitive Impairment
NCT02212119Phase 2Completed
- Sponsor
- Assistive Technology Clinic
- Start
- Dec 2010
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in paratonia, sponsored by Assistive Technology Clinic. Started Dec 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
paratonia
Beyond the preview
Go deeper on NCT02212119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212119.